NB3.STU Neurocrine Biosciences Inc

- EUR
Market cap
-
P/E
22.2x
P/B
4.00x
ROE
18.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NB3.STU undervalued?

Graham number

The Graham number of Neurocrine Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Neurocrine Biosciences Inc fundamental analysis

No fundamental analysis for Neurocrine Biosciences Inc yet.

Neurocrine Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.